1st Quarter - Report
CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP
Client
Income
$47,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| AMY SHANK | 2001-2002 Ofc. of Asst. GOP Leader Don Nickles |
| DAVID THOMPSON | — |
Health Issues HCR
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| AMY SHANK | 2001-2002 Ofc. of Asst. GOP Leader Don Nickles |
| DAVID THOMPSON | — |
Pharmacy PHA
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| AMY SHANK | 2001-2002 Ofc. of Asst. GOP Leader Don Nickles |
| DAVID THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.